NTU ASTAR Nanopore research
Scientists from Nanyang Technological University, Singapore (NTU Singapore) and the Agency for Science, Technology and Research (A*STAR) have showed that applying “temporal pressure” to the skin of mice can create a new way to deliver drugs.
In a paper published in Science Advances, the researchers showed that bringing together two magnets so that they pinch and apply pressure to a fold of skin, led to short term changes in the skin barrier and specifically the formation of “micropores” underneath its surface.
In tests, they showed that these micropores, of about 3 micrometres in area, allowed drugs applied on the surface of the skin to diffuse through it more easily. Six times greater quantity of drug diffused through the skin of mice with the micropores compared to the skin of mice which did not receive the temporal pressure treatment.
Lead author of the paper, Dr Daniel Lio, who did this research as part of his doctoral thesis at NTU’s School of Chemical and Biomedical Engineering, Interdisciplinary Graduate Programme, said that while needles and microneedle injections damage the skin, micropores could pave the way towards painless transdermal delivery of drugs such as insulin.
“Our research project was first inspired by the traditional Chinese medicine ‘tuina’ therapy where physicians rub and apply pressure on skin and muscle tissue and apply a topical ointment,” explained Dr Lio, who is now working at A*STAR’s Enterprise Group.
Going a step further, the joint team which included Prof David Laurence Becker from NTU Lee Kong Chian School of Medicine and Skin Research Institute of Singapore; Assoc Prof Wang Xiaomeng from the NTU Lee Kong Chian School of Medicine, and Assistant Prof Xu Chenjie from the School of Chemical and Biomedical Engineering, tested the delivery of insulin through the skin of mice using the new method.
Reducing skin damage and pain from delivering drugs through skin
Experimental results showed that nanoparticles and insulin were effectively delivered through the skin of mice, at molecular masses up to 20,000 daltons.
This mass is 40 times the largest currently reported in the scientific literature for transdermal drug delivery (i.e. via patches), which is 500 daltons.
The amount of drug delivered via the temporal pressure method was also comparable to the amount delivered by a microneedle patch – dozens of needles smaller than the width of a human hair made from biocompatible compounds, commonly used to deliver small amounts of drugs through the skin over time.
Compared to conventional injection where the skin has to be penetrated and there is a risk of a hypoglycaemia effect – when the injected insulin acts too fast and the patient gets dizzy – the new method is able to slowly deliver drugs over time without breaking the skin, thus causing less pain.
In experiments, the team also found that with their method, cells in the skin layer (epidermis) were observed to have an increase in the number of “gap junctions” and a reduction in “tight junctions”. These junctions control the amount of molecules being delivered between the cells: if there is an increased expression of gap junctions, more molecules can be delivered across the cell barrier, while tight junctions restrict the extracellular movement of molecules.
In the animal experiments, two magnets were used to apply pressure on the mouse dorsal skin for 1 or 5 minutes, depending on how fast the drug delivery is needed, before being removed and the drug is then topically applied like a cream.
The team hypothesised that for drugs that need to be delivered more slowly or in smaller doses – 1 minute would be sufficient, while for drugs to be delivered faster, more micropores would be needed, therefore 5 minutes would be required.
The drug was then left for 12 hours before the skin was imaged with fluorescent microscopy to see to what extent the drug had penetrated through the skin.
The team compared three types of skin: skin that received pressure treatment, skin which had not, and skin which had drugs delivered through microneedles.
Skin that received pressure treatment had similar amounts of drug delivered through the skin to that found with a microneedle patch, while skin that did not receive the pressure treatment had significantly less drug delivered.
Micropores were also observed to disappear a day after they were formed, which suggests that the skin cells have filled up the gaps.
Prof Becker, whose research expertise is in tissue repair and regeneration, said their paper highlighted the potential to use this method which could alleviate the need for diabetes patients to inject insulin multiple times daily using conventional needles and syringes.
“Patients who have to inject drugs daily, such as insulin, are constantly asking whether there is another way to deliver their medicines that doesn’t involve hurting or penetrating the skin. Our new findings hold promise for them and we hope that we can refine this method so that one day it may be possible to deliver enough drugs through the skin via a patch and to rid them of their daily injections,” Prof Becker added.
The Latest Updates from Bing News & Google News
Go deeper with Bing News on:
Drug delivery through the skin
- Focus on Research: Dr Eoin O’Cearbhaill, I-Formon July 2, 2021 at 7:21 am
Can you take us through it? Microneedle patches offer the ... with the goal of painlessly accessing dermal layers for drug delivery or for biosensing applications. Human skin varies in thickness ...
- When biotech meets reality TV – Starton Therapeutics faces the Unicorn Hunterson July 2, 2021 at 3:47 am
Starton Therapeutics is bypassing the traditional venture capital route to raise money for its transdermal delivery technology that delivers medicine through the skin. pharmaphorum hears why the ...
- Topical Drug Delivery Market - Emerging Trends to Boost the Global Industry Growthon June 30, 2021 at 6:41 am
Recent Developments in the Global Topical Drug Delivery Mechanism Market:# In 2019, Mylan launched its DICLOFENAC SODIUM Gel.# In 2019, Nestlé Skin Health opened a new office in Malaysia to accelerate ...
- Topical Drug Delivery Market Size, Share Revenue to Grow At 7.5% CAGR Through 2027on June 30, 2021 at 2:50 am
The global Topical Drug Delivery market garnered revenue around USD 96.1 Billion in 2020 and projected to reach USD 131.3 Billion in 2027, with at a compound annual growth rate (CAGR) of 7.5% ...
- Transdermal Drug Delivery System Market Segments, Companies, Regions, Growth Factors and Forecast By 2027on June 29, 2021 at 10:57 am
Global Transdermal Drug Delivery System Market to reach USD 8.4 billion by 2027. Global Transdermal Drug Delivery System Market is valued at approximately USD 6.2 billion in 2020 and is anticipated to ...
Go deeper with Google Headlines on:
Drug delivery through the skin
Go deeper with Bing News on:
- Pharmacists lauded for ramping up drug delivery serviceson July 2, 2021 at 2:00 pm
When pharmacies turned to online channels to deliver medicine during the pandemic, pharmacist Vernadine Goh knew the switch would be challenging for her elderly patients.. Read more at ...
- Arcutis (ARQT) Terminates Study of Drug to Treat Vitiligoon July 2, 2021 at 8:01 am
Further analysis pointed out that the critical driver for the lack of efficacy was inadequate local drug delivery to the skin. In the year so far, Arcutis’ stock has declined 5.8% against the industry ...
- The Next Generation Drug Eluting Stent Market To Grow Through Partnerships Amongst Market Participantson July 2, 2021 at 7:10 am
The Next Generation Drug Eluting Stent Market is all set to incorporate the ongoing as well as future trend. Various types of drug-eluting stents (DES) are available in the market and has dramatically ...
- SOLUtion Medical, a drug delivery device startup out of NextFab, is ready ‘to get some gas in the gas tank’on July 1, 2021 at 4:15 pm
The company, which makes patient-friendly drug delivery systems for reconstitutable drugs, is hiring top leadership and ramping up fundraising.
- Europe Drug Delivery Market Report 2021: Market Size and Growth Projections to 2028on July 1, 2021 at 11:17 am
Drug delivery systems are designed advancements for the targeted shipping and managed launch of healing dealers.